📰 Project Integrum News
Project Integrum News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Project Integrum. Real-time updates on events, politics, business and more.
January 24, 2024
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.
January 23, 2024
BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics
December 18, 2023
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 a global biotech company focusing on the discovery and development of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Ona Therapeutics Ona a Spanish biotech company specialized in unravelling novel biology to design biopharmaceuticals attacking advanced cancer.
September 7, 2023
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel...
September 7, 2023
Biocytogen Pharmaceuticals a global biotech company focusing on the discovery of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Myricx Bio a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates ADCs.
August 18, 2023
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 announced today that its Project Integrum has completed 2 core milestones and its antibody business is now entering a new stage of rapid growth.
July 5, 2023
/PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of...